These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 28963556

  • 1. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice.
    Nakai K, He YY, Nishiyama F, Naruse F, Haba R, Kushida Y, Katsuki N, Moriue T, Yoneda K, Kubota Y.
    Sci Rep; 2017 Sep 29; 7(1):12473. PubMed ID: 28963556
    [Abstract] [Full Text] [Related]

  • 2. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S, Oka T, Sugaya M, Sato S.
    J Dermatol Sci; 2016 Jun 29; 82(3):175-88. PubMed ID: 26976687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
    Kawaguchi M, Oka T, Sugaya M, Suga H, Kimura T, Morimura S, Fujita H, Sato S.
    J Dermatol Sci; 2018 Apr 29; 90(1):35-45. PubMed ID: 29305258
    [Abstract] [Full Text] [Related]

  • 6. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L, Xue H, Qi R, Wang Y, Yuan L.
    J Transl Med; 2018 Mar 10; 16(1):59. PubMed ID: 29523162
    [Abstract] [Full Text] [Related]

  • 7. STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis.
    Bai L, Fang H, Xia S, Zhang R, Li L, Ochando J, Xu J, Ding Y.
    Biochem Biophys Res Commun; 2018 Jun 22; 501(2):563-569. PubMed ID: 29750958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
    Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.
    PLoS One; 2016 Jun 22; 11(11):e0166433. PubMed ID: 27846260
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
    El Malki K, Karbach SH, Huppert J, Zayoud M, Reissig S, Schüler R, Nikolaev A, Karram K, Münzel T, Kuhlmann CR, Luhmann HJ, von Stebut E, Wörtge S, Kurschus FC, Waisman A.
    J Invest Dermatol; 2013 Feb 22; 133(2):441-51. PubMed ID: 22951726
    [Abstract] [Full Text] [Related]

  • 12. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
    Nadeem A, Al-Harbi NO, Al-Harbi MM, El-Sherbeeny AM, Ahmad SF, Siddiqui N, Ansari MA, Zoheir KM, Attia SM, Al-Hosaini KA, Al-Sharary SD.
    Pharmacol Res; 2015 Sep 22; 99():248-57. PubMed ID: 26149470
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition and augmentation of alternative macrophage activation by progesterone.
    Menzies FM, Henriquez FL, Alexander J, Roberts CW.
    Immunology; 2011 Nov 22; 134(3):281-91. PubMed ID: 21977998
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A, Ahmad SF, Al-Harbi NO, El-Sherbeeny AM, Alasmari AF, Alanazi WA, Alasmari F, Ibrahim KE, Al-Harbi MM, Bakheet SA, Attia SM.
    Int Immunopharmacol; 2020 Mar 22; 80():106215. PubMed ID: 31982823
    [Abstract] [Full Text] [Related]

  • 16. Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis.
    Furue M.
    Int J Mol Sci; 2020 Jul 29; 21(15):. PubMed ID: 32751111
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages.
    Joshi AD, Oak SR, Hartigan AJ, Finn WG, Kunkel SL, Duffy KE, Das A, Hogaboam CM.
    BMC Immunol; 2010 Oct 19; 11():52. PubMed ID: 20958987
    [Abstract] [Full Text] [Related]

  • 18. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis.
    Xiao C, Zhu Z, Sun S, Gao J, Fu M, Liu Y, Wang G, Yao X, Li W.
    J Dermatol Sci; 2017 Mar 19; 85(3):170-177. PubMed ID: 27964879
    [Abstract] [Full Text] [Related]

  • 19. The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling.
    Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, Outram S, Leibovich SJ.
    Inflammation; 2013 Aug 19; 36(4):921-31. PubMed ID: 23504259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.